Pacific Shuanglin Bio-pharmacy Co., Ltd.

¥9.72As of Sun 8 Nov 2026, 12:00 UTC
SZSE:000403Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (3.29%)
Div yield 3.09%
ROE 2.67%
Biotechnology
Beta (5Y) 0.43
PE TTM 43.59
TSR TTM (37.26%)
Mkt cap ¥9.113B
ROIC 3.19%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥11
13.67%
58.57%
Hold 4|2|6|7|10
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.14
0.15
0.14
0.14
(4.21%)
1.16%
0.93%
1.87%
Revenue¥B
1.035
1.067
1.094
1.126
2.29%
4.50%
4.62%
8.09%
Peers (US$1.366B)
Cap (US$)
PE
1.375B
198.4x
Capital
TTM
5Y
10Y
Leveragex
1.017
0.425
0.310
EBIT/Intx
0.121
0.078
0.078
Own earn%
(258.15)
(72.11)
(75.21)
Sh yield%
47.71
37.35
34.41
Owners
Insiders/Inst%
8.30
50.62
Short interest%
3.98
SBC / revenue%
5.89
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
24–32
$1 testx
0.0
Incr. ROIC%
37